9 Meters Biopharma, Inc.
OTC: NMTRQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Peter H. R. Green
- Employees
- 10
- Headquarters
- Raleigh, United States
- IPO year
- 2016
- Market cap
- $145.0
- Website
- https://www.9meters.com
Loading NMTRQ…
Loading profile data…Frequently asked questions about NMTRQ
What does 9 Meters Biopharma, Inc. (NMTRQ) do?
Operating as a clinical-stage biopharmaceutical firm, 9 Meters Biopharma, Inc. specialized in creating therapies for individuals in North America afflicted by rare digestive illnesses, various gastrointestinal disorders lacking effective treatments, and other debilitating conditions. Its primary therapeutic candidate was Vurolenatide, a long-act...
Where does NMTRQ trade?
9 Meters Biopharma, Inc. (NMTRQ) trades on the Other OTC.
What sector is NMTRQ in?
9 Meters Biopharma, Inc. (NMTRQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of 9 Meters Biopharma, Inc.?
Peter H. R. Green is the chief executive officer of 9 Meters Biopharma, Inc. (NMTRQ).
Where is 9 Meters Biopharma, Inc. headquartered?
9 Meters Biopharma, Inc. is headquartered in United States.
Does NMTRQ pay a dividend?
9 Meters Biopharma, Inc. (NMTRQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NMTRQ go public?
9 Meters Biopharma, Inc. (NMTRQ) completed its initial public offering in 2016.